Companies

Exact Sciences

Mentioned in 1 analyzed podcast episode across 1 show

Episode Mentions

Bloomberg Intelligence

Bloomberg Intelligence · Jul 16, 2026

Lilly Strikes $3.8 Billion Deal for Psychedelic Drugmaker

$23B acquisition by Abbott closed in Q1; cancer diagnostic segment growing mid-teens, includes Cologuard brand

Psychedelic Drug Development and RegulationEli Lilly M&A Strategy and Contingent Value RightsPCSK9 Inhibitors and Cholesterol Management
View Analysis